Other Obesity Drug Companies Worth Watching The next wave of obesity drug development is drawing in more large pharma players
Wegovy (0.252.4 mg SC weekly) is approved for chronic weight management in obesity or overweight with comorbidities
In immature rats, GH treatment induced testicular growth and germ cell differentiation [12]
Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL (1997) Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells
GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, with tirzepatide providing greater health benefits at lower cost compared to semaglutide
Taking a new medication can feel a little intimidating, especially when it's an injection